Pfizer COVID shots appear 73% effective in children under 5

COVID-19 vaccine
Credit: Pixabay/CC0 Public Domain

Pfizer's COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring, the company announced Tuesday.

Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay. Only about 6% of ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics.

Health authorities authorized tot-sized vaccine doses made by Pfizer and its partner BioNTech based on a study showing they were safe and produced high levels of virus-fighting antibodies. But there was only preliminary data on how that translated into effectiveness against symptomatic COVID-19.

The new update analyzed COVID-19 diagnoses between March and June in Pfizer's ongoing study of the three-dose vaccine. There were 21 COVID-19 cases among the 351 tots who got dummy shots—compared to just 13 among the 794 youngsters given three vaccine doses.

The child cases primarily were caused by the BA.2 version that was circulating at the time. Today, another omicron relative, BA.5, is causing most COVID-19 cases in the U.S. and much of the world.

In and adults, the COVID-19 vaccines have been used long enough to prove that they remain strongly protective against and death even as the coronavirus mutates—while early protection against infection wanes. Still, scientists track that initial effectiveness rate as extra evidence of vaccine performance—and to look for signs of how they initially hold up against new mutants.

Pfizer this week asked U.S. regulators to authorize modified that better match the newest omicron variants for people 12 and older as boosters this fall. The company said it also is developing updated shots for kids under 12.

© 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: Pfizer COVID shots appear 73% effective in children under 5 (2022, August 23) retrieved 7 December 2022 from https://medicalxpress.com/news/2022-08-pfizer-covid-shots-effective-children.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Pfizer seeks OK of updated COVID vaccine booster for fall

14 shares

Feedback to editors